Scandinavian Journal of Gastroenterology · 2019 · 16 citations · 22 references
Life SciencesInfectious DiseasesMicrobiologyMolecular VirologyPharmacogeneticsVirologyAntiviral AgentsAntiviral Drug ResistanceAntiviral ResistanceAntiviral TherapyViral HepatitisViral InfectionsAntiviral Resistance MutationsAntiviral TreatmentDirect-acting Antiviral AgentsDirect-acting AntiviralsHepatitis C Virus ResistanceResistance-associated MutationsResistance-associated Viral VariantsTreatment Outcome Analysis
The results from this real-life study are in accordance with the findings of the randomised controlled trials in 2015 and the EASL-guidelines of 2016, thus, baseline Y93H impacts on DCV and VEL treatment outcome.
22
EASL Recommendations on Treatment of Hepatitis C 2018
Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations
EASL Recommendations on Treatment of Hepatitis C 2016
Journal of Hepatology · 2016 · 978 citations